UBS Group’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17M | Sell |
152,981
-85,216
| -36% | -$1.77M | ﹤0.01% | 3440 |
|
|
2025
Q1 | $4.12M | Sell |
238,197
-5,866
| -2% | -$102K | ﹤0.01% | 3117 |
|
|
2024
Q4 | $6.62M | Buy |
244,063
+204,983
| +525% | +$5.56M | ﹤0.01% | 2730 |
|
|
2024
Q3 | $1.72M | Buy |
39,080
+33,717
| +629% | +$1.48M | ﹤0.01% | 3160 |
|
|
2024
Q2 | $211K | Sell |
5,363
-77,351
| -94% | -$3.04M | ﹤0.01% | 4510 |
|
|
2024
Q1 | $3.55M | Buy |
82,714
+23,077
| +39% | +$989K | ﹤0.01% | 2500 |
|
|
2023
Q4 | $2.43M | Buy |
+59,637
| New | +$2.43M | ﹤0.01% | 2660 |
|
|
2023
Q3 | – | Sell |
-2
| Closed | -$83 | – | 8442 |
|
|
2023
Q2 | $83 | Buy |
+2
| New | +$83 | ﹤0.01% | 7451 |
|